Jeremy Schreiber,

MSN, PMHNP-BC

Jeremy Schreiber

MSN, PMHNP-BC

Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care

Jeremy Schreiber,

MSN, PMHNP-BC

Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care

Jeremy Schreiber is a healthcare professional with a strong focus on mental health. Currently serving as adjunct faculty for West Liberty University in West Liberty, West Virginia, Jeremy is also a clinical preceptor for numerous educational institutions across the nation. Dedicated to the advancement of mental health care, he obtained his Master of Science in Nursing degree from Ohio State University, and he is a current member of the Mental Health Working Group for the Alliance for Patient Access and the TD Expert Panel for the CureSZ foundation. Jeremy is the Founder and CEO of Enlighten Health Care, LLC, a leading healthcare organization based in Wheeling, West Virginia, where he actively practices as a Psychiatric-Mental Health Nurse Practitioner.

Jeremy's Shared Resources

Understanding and Managing Tardive Dyskinesia and Dystonia: Symptoms, Causes, and Treatments

This article covers symptoms, causes, and treatments for tardive dyskinesia and dystonia, both triggered by medications used for mental disorders,...
Jeremy Schreiber,

Jeremy Schreiber,

MSN, PMHNP-BC
Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC
Read More >

The Extensive Impact of Tardive Dyskinesia Physically, Psychologically, and Socially

Researchers of a study assessed the multifaceted impact of tardive dyskinesia (TD) on patients through an online survey that took...
Jeremy Schreiber,

Jeremy Schreiber,

MSN, PMHNP-BC
Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC
Read More >

Study Leverages Lean Six Sigma to Enhance Tardive Dyskinesia Management in Antipsychotic Treatment

In a study, researchers provided insights on identifying and treating tardive dyskinesia (TD), particularly in patients treated with antipsychotics. They...
Jeremy Schreiber,

Jeremy Schreiber,

MSN, PMHNP-BC
Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC
Read More >

Growing Interest in CBD for Tardive Dyskinesia Despite Limited Scientific Evidence

Authors of an article summarized information on cannabidiol (CBD), a major component of the cannabis sativa plant, and tardive dyskinesia...
Jeremy Schreiber,

Jeremy Schreiber,

MSN, PMHNP-BC
Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC
Read More >

Study Reveals Ethnicity-Based Differences in Tardive Dyskinesia Outcomes Among Patients With Schizophrenia

Researchers of a study focused on understanding the long-term course and outcome of tardive dyskinesia (TD) in patients with schizophrenia...
Jeremy Schreiber,

Jeremy Schreiber,

MSN, PMHNP-BC
Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC
Read More >

RE-KINECT Study Results: Physical Wellness and Social Functioning Impact

In a real-world study of possible patients with tardive dyskinesia (TD) treated with antipsychotics, researchers aimed to understand its impact...
Jeremy Schreiber,

Jeremy Schreiber,

MSN, PMHNP-BC
Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC
Read More >
Load More

Privacy Policy
Terms of Use

Company
Contact

Partner with Us
Ambassador Program

© 2024 Point of Care Network, LLC. All Rights Reserved.

Privacy Policy Terms of Use Company Contact Partner with Us Ambassador Program

© 2024 Point of Care Network, LLC. All Rights Reserved.

Share